Humana Inc. (NYSE:HUM) Shares Bought by Harbour Investments Inc.

Harbour Investments Inc. increased its stake in Humana Inc. (NYSE:HUM) by 48.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 642 shares of the insurance provider’s stock after purchasing an additional 210 shares during the quarter. Harbour Investments Inc.’s holdings in Humana were worth $203,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Creative Financial Designs Inc. ADV lifted its stake in shares of Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. raised its holdings in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. acquired a new stake in Humana in the third quarter worth approximately $29,000. Ashton Thomas Securities LLC bought a new position in Humana during the 3rd quarter valued at $31,000. Finally, Your Advocates Ltd. LLP increased its position in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on HUM shares. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 target price on shares of Humana in a research note on Tuesday, October 1st. Barclays lifted their price objective on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price for the company in a research note on Tuesday, October 8th. Stephens restated an “equal weight” rating and set a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Finally, Royal Bank of Canada dropped their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $315.86.

Humana Price Performance

Shares of NYSE:HUM opened at $275.67 on Monday. The firm has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a P/E/G ratio of 2.17 and a beta of 0.52. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The business has a fifty day simple moving average of $281.36 and a 200 day simple moving average of $331.94.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, sell-side analysts predict that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.28%. Humana’s dividend payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.